COMMUNIQUÉS West-GlobeNewswire
-
Information marché Financement du projet de transformation FOCUS-27
06/06/2024 - 17:54 -
Market update : FOCUS-27 transformation project financing
06/06/2024 - 17:54 -
Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/06/2024 - 18:00 -
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
06/06/2024 - 18:00 -
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
06/06/2024 - 18:14 -
TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability
06/06/2024 - 18:45 -
Los Angeles Students Experience Behavioral Transformation Through Mindfulness Program
06/06/2024 - 19:00 -
New Weight Loss Drugs Pose Anesthesia Risk, according to Journal of American Physicians and Surgeons
06/06/2024 - 19:02 -
Repurposed Drugs Needed for COVID-19, according to Journal of American Physicians and Surgeons
06/06/2024 - 19:45 -
Nextech Appoints Rusty Frantz as Chief Executive Officer
06/06/2024 - 20:00 -
Bad-faith Physician Peer Review May Violate False Claims Act and Other Laws, according to Journal of American Physicians and Surgeons
06/06/2024 - 20:07 -
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
06/06/2024 - 14:30 -
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
06/06/2024 - 14:30 -
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
06/06/2024 - 14:30 -
MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
06/06/2024 - 14:30 -
Retrieve Medical Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems
06/06/2024 - 14:30 -
SeaStar Medical Announces 25-for-1 Reverse Stock Split
06/06/2024 - 14:30 -
Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System
06/06/2024 - 14:30 -
Ipsen nomme Josep Catllà, en qualité de Vice-Président Exécutif, Chief Corporate Affairs Officer
06/06/2024 - 14:30
Pages